INDIVIDUAL ARTICLE: Sugar Sag: What Is Skin Glycation and How Do You Combat It?

Zoe Diana Draelos MD has the following relevant financial relationships: Contracted researcher and consultant for: Aclaris Therapeutics, Inc.; Aesthetics Biomedical; Allergan, Almirall; Amderma; Amgen, Inc.; AOBiome; Arcutis Biotherapeutics, Inc.; Bausch Heath; Bayer AG; Biopelle; Boehringer Ingelheim Pharmaceuticals, Inc.; Boots; Botanix Pharmaceuticals; Brickell Biotech, Inc.; Burt's Bees; Carpe; Chattem Chemicals Inc.; The Chlorox Company; Clarke Pharmaceuticals, Inc.; Colgate-Palmolive Company; Coloplast Corp.; Combe; DelArrivo, Inc.; Dermavant Sciences, Inc.; Dermira, Inc.; Dial; Dr. Reddy's Laboratories Ltd.; Estée Lauder Inc.; E.T. Browne Drug Co., Inc.; Evolus, Inc.; Ferndale Laboratories, Inc.; Foamix Pharmaceuticals Ltd.; Galderma Laboratories, LP; Genentech, Inc.; General Mills, Inc.; GlaxoSmithKline; Helix Biomedix, Inc.; Henkel; International Specialty Products, Inc.; Johnson & Johnson Services, Inc.; Kamedis; Kao Corporation; La Roche-Posay; LEO Pharma Inc.; Lilly; L’Oreal; Maruho Co., Ltd.; Merck; Nice-Pak Products, Inc.; Novartis; Nu Skin; Perricone MD; Perrigo Company plc; Pfizer Inc.; PharmaNet, Inc.; Proctor & Gamble; Reckitt Benckiser Group plc; Revance Therapeutics, Inc.; Rodan & Fields, LLC; Roivant Sciences Ltd; Sanofi; SkinCeuticals; Symrise; Taro Pharmaceuticals Industries Ltd.; Teoxane; TEVA Pharmaceuticals USA, Inc.; Topix Pharmaceuticals, Inc.; Vanda Pharmaceuticals Inc.;  Verrica Pharmaceuticals; Warner-Chilcott; WellSpring Pharmaceutical Corporation; YA-MAN Ltd; ZO Skin Health, Inc. 

Commercial Supporter: Supported by an independent educational grant from SkinCeuticals.

1. Zheng W, Li H, Go Y, et al. Research advances on the damage mechanism of skin glycation and related inhibitors. Nutrients. 2022;14:4588. 
2. Zgutka K, Tkacz M, Tomasiak P, et al. A role for advanced glycation end products in molecular ageing. Int J Mol Sci. 2023;24:9881. 
3. Chen C-Y, Zhang J-Q, Li L, et al. Advanced glycation end products in the skin: Molecular mechanisms, methods of measurement, and inhibitory pathways. Front Med (Lausanne). 2022;9:837222. 
4. Twarda-Clapa A, Olezak A, Bialkowska AM, et al. Advanced glycation end-products (AGEs): Formation, chemistry, classification, receptors, and diseases related to AGEs. Cells. 2022;11:1312. 
5. Kang Q, Dai H, Jiang S, et al. Advanced glycation end products in diabetic retinopathy and phytochemical therapy. Front Nutr. 2022;9:1037186. 
6. Inan-Eroglu E, Ayaz A, Buyuktuncer Z, et al. Formation of advanced glycation endproducts in foods during cooking process and underlying mechanisms: a comprehensive review of experimental studies. Nutr Res Rev. 2020;33:77-89. 
7. Garone M, Howard J, Fabrikant J. A review of common tanning methods. J Clin Aesthet Dermatol. 2015;8:43-47. 
8. Smith KR, Granberry M, Tan MC, et al. Dihydroxyacetone induces G2/M arrest and apoptotic cell death in A375P melanoma cells. Environ Toxicol. 2018;33:333-342. 
9. Perer J, Jandova J, Fimbres J, et al. The sunless tanning agent dihydroxyacetone induces stress response gene expression and signaling in cultured human keratinocytes and reconstructed epidermis. Redox Biol. 2020;36:101594. 
10. Petersen AB, Wulf HX, Gniadecki R, et al. Dihydroxyacetone, the active browning ingredient in sunless tanning lotions, induces DNA damage, cell-cycle block and apoptosis in cultured HaCaT keratinocytes. Mutat Res. 2004;560:173-186. 
11. Yourick JJ, Koenig ML, Yourick DL, et al. Fate of chemicals in skin after dermal application: does the in vitro skin reservoir affect the estimate of systemic absorption? Toxicol Appl Pharmacol. 2004;195:309-320. 
12. de Araújo R, Lobo M, Trindade K, et al. Fibroblast growth factors: A controlling mechanism of skin aging. Skin Pharmacol Physiol. 2019;32:275-282. 
13. Basta G, Lazzerini G, Turco SD, et al. At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products. Arterioscler Thromb Vasc Biol. 2005;25:1401-1407
14. Yeh CH, Sturgis L, Haidacher J, et al. Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion. Diabetes. 2001;50:1495-1504.
15. Gkogkolou P, Böhm M. Advanced glycation end products (AGEs): Emerging mediators of skin aging. In: Farage M, Miller K, Maibach H, eds. Textbook of Aging Skin. Berlin, Germany: Springer-Verlag. 2016;1-12.
16. Gkogkolou P, Böhm M. Advanced glycation end products: Key players in skin aging? Dermatoendocrinol. 2012;4:259-270.
17. Qing C. The molecular biology in wound healing & non-healing wound. Chin J Traumatol. 2017;20:189-193.
18. Jud P, Sourij H. Therapeutic options to reduce advanced glycation end products in patients with diabetes mellitus: A review. Diabetes Res Clin Pract. 2019;148:54-63.
19. Uruska A, Gandecka A, Araszkiewicz A, et al. Accumulation of advanced glycation end products in the skin is accelerated in relation to insulin resistance in people with type 1 diabetes mellitus. Diabet Med. 2019;36:620-625.
20. Yu Y, Thorpe SR, Jenkins AJ, et al. Advanced glycation end-products and methionine sulphoxide in skin collagen of patients with type 1 diabetes. Diabetologia. 2006;49:2488-2498.
21. Quondamatteo F. Skin and diabetes mellitus: what do we know? Cell Tissue Res. 2014;355:1-21.
22. Argyropoulos AJ, Robichaud P, Balimunkwe RM, et al. Alterations of dermal connective tissue collagen in diabetes: Molecular basis of aged-appearing skin. PLoS One. 2016;11:e0153806.
23. Cepas V, Collino M, Mayo JC, et al. Redox signaling and advanced glycation endproducts (AGEs) in diet-related diseases. Antioxidants (Basel). 2020;9:142.
24. Uribarri J, Peppa M, Xai W, et al. Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients. Am J Kidney Dis. 2003;42:532-538.
25. Chao P-C, Huang C-N, Hsu C-C, et al. Association of dietary AGEs with circulating AGEs, glycated LDL, IL-1α and MCP-1 levels in type 2 diabetic patients. Eur J Nutr. 2010;49:429-434.
26. Rehman MU, Farooq A, Ali R, et al. Preclinical evidence for the pharmacological actions of glycyrrhizic acid: A comprehensive review. Curr Drug Metab. 2020;21:436-465.
27. Li Y, Zhang J-J, Xu D-P, et al. Bioactivities and health benefits of wild fruits. Int J Mol Sci. 2016;17:1258.
28. Kalt W, Cassidy A, Howard LR, et al. Recent research on the health benefits of blueberries and their anthocyanins. Adv Nutr. 2020;11:224-236.
29. Draelos ZD, Yatskayer M, Raab S, et al. An evaluation of the effect of a topical product containing C-xyloside and blueberry extract on the appearance of type II diabetic skin. J Cosmet Dermatol. 2009; 8:147-151. 
30. Koizumi S, Okada Y, Miura S, et al. Ingestion of a collagen peptide containing high concentrations of prolyl-hydroxyproline and hydroxyprolyl-glycine reduces advanced glycation end products levels in the skin and subcutaneous blood vessel walls: a randomized, double-blind, placebo-controlled study. Biosci Biotechnol Biochem. 2023;87:883-889. 
31. Anwar S, Khan S, Almatroudi A, et al. A review on mechanism of inhibition of advanced glycation end products formation by plant derived polyphenolic compounds. Mol Biol Rep. 2021;48:787-805. 
32. Draelos ZD. Aging skin: the role of diet: facts and controversies. Clin Dermatol. 2013;31:701-706. 
33. Zawada A, Machowiak A, Rychter AM, et al. Accumulation of advanced glycation end-products in the body and dietary habits. Nutrients. 2022;14:3982. 
34. Zheng W, Li H, Go Y, et al. Research advances on the damage mechanism of skin glycation and related inhibitors. Nutrients. 2022;14:4588. 
35. Ruiz HH, Ramasamy R, Schmidt AM. Advanced glycation end products: Building on the concept of the "common soil" in metabolic disease. Endocrinology. 2020;161:bqz006. 
36. Rungratanawanich W, Qu Y, wang Z, et al. Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury. Exp Mol Med. 2021;53:168-188. 
37. Prasad C, Imrhan V, Marotta F, et al. Lifestyle and advanced glycation end products (AGEs) burden: Its relevance to healthy aging. Aging Dis. 2014;5:212-217. 
38. Draelos ZD. Revisiting the skin health and beauty pyramid: A Clinically Based Guide to Selecting Topical Skincare Products. J Drugs Dermatol. 2021;20:695-699. 
39. Draelos ZD. The multifunctional value of sunscreen-containing cosmetics. Skin Therapy Lett. 2011;16:1-3. 
40. Lim HW, Draelos ZD, eds. Clinical Guide to Sunscreens and Photoprotection. 1st ed. CRC Press;2009.